Gene clues could explain who benefits from rejection therapy
NCT ID NCT07316829
First seen Jan 11, 2026 · Last updated Jun 11, 2026 · Updated 23 times
Summary
This study looks at gene activity in blood cells from 30 kidney or lung transplant patients who have chronic rejection. Researchers want to find out why some patients improve with a treatment called extracorporeal photopheresis (ECP) while others do not. By comparing gene profiles before and after treatment, they hope to identify molecular patterns linked to better outcomes. This is an observational study, meaning no new treatment is being tested—only existing data and samples are analyzed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
Conditions
Explore the condition pages connected to this study.